Effect of Physical Therapy on Breast Cancer Related Lymphedema

NCT ID: NCT02015897

Last Updated: 2023-01-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-01-31

Study Completion Date

2017-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to investigate if Complete Decongestive Therapy is equally effective whether it includes manual lymphatic drainage or not in the treatment of lymphoedema among patients with breast cancer.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Physical therapy treatment of patients with lymphoedema includes treatment based on the principles of 'Complete Decongestive Therapy' (CDT). CDT consists of following components; skin care, manual lymphatic drainage, bandaging and exercises. Regarding what type of treatment of treatments is most effective, the scientific evidence is sparse. Studies have focused on the time-consuming manual lymphatic drainage, but the scientific evidence is not consistent.

A randomized, single-blind, equivalence trial. A total of 160 breast cancer patients with lymphoedema will be recruited from 3 hospitals and randomised into one of two treatment groups: A: Complete Decongestive TherapyA (incl. manual drainage) or B: Complete Decongestive TherapyB (except manual lymphatic drainage

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lymphoedema Breast Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Physical TherapyB

Group B

Group Type ACTIVE_COMPARATOR

Physical TherapyA

Intervention Type PROCEDURE

Group A:

* Skin care
* Manual lymphatic drainage
* Bandaging using Coban™2Lite
* Guidance on physical activity

Physical TherapyA

Group A

Group Type PLACEBO_COMPARATOR

Physical TherapyB

Intervention Type PROCEDURE

Group B:

* Skin care
* Bandaging using Coban™2Lite
* Guidance on physical activity

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Physical TherapyA

Group A:

* Skin care
* Manual lymphatic drainage
* Bandaging using Coban™2Lite
* Guidance on physical activity

Intervention Type PROCEDURE

Physical TherapyB

Group B:

* Skin care
* Bandaging using Coban™2Lite
* Guidance on physical activity

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The diagnose breast cancer regardless of date for operation and identified lymphoedema
* Precede ultrasonic scanning of axilla in order to exclude local relapse
* Lymphoedema \> 2 cm i.e. stage II-III
* Completed radiotherapy and/or chemotherapy at least 2 months prior inclusion

Exclusion Criteria

* Relapse of breast cancer
* Untreated infection
* Untreated heart failure
* Untreated renal failure
* Untreated deep venous thrombosis in the arm
* Unable to participate in physiotherapy treatment and/or not able to understand instructions
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Esbjerg Hospital - University Hospital of Southern Denmark

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Valgerdur Hilmarsdottir Gram

Associate Professor, PhD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bibi Gram, PhD

Role: STUDY_DIRECTOR

THe Hospital of Southwest Denmark

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital of Southwest Denmark

Esbjerg, Region Syddanmark, Denmark

Site Status

Department of Rehabilitation, Odense University Hospital

Odense, Region Syddanmark, Denmark

Site Status

Department of Physical Therapy, Lillebaelt Hospital

Vejle, Region Syddanmark, Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

References

Explore related publications, articles, or registry entries linked to this study.

Tambour M, Holt M, Speyer A, Christensen R, Gram B. Manual lymphatic drainage adds no further volume reduction to Complete Decongestive Therapy on breast cancer-related lymphoedema: a multicentre, randomised, single-blind trial. Br J Cancer. 2018 Nov;119(10):1215-1222. doi: 10.1038/s41416-018-0306-4. Epub 2018 Oct 24.

Reference Type DERIVED
PMID: 30353049 (View on PubMed)

Tambour M, Tange B, Christensen R, Gram B. Effect of physical therapy on breast cancer related lymphedema: protocol for a multicenter, randomized, single-blind, equivalence trial. BMC Cancer. 2014 Apr 3;14:239. doi: 10.1186/1471-2407-14-239.

Reference Type DERIVED
PMID: 24708851 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://www.sydvestjysksygehus.dk

Link to the Hospital of Southwest Denmark

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

S-20130091

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.